Hannah Yamagata

12PUBLICATIONS
45CO-AUTHORS
NanometrologyHaematological tumoursNanoscale characterisationCancer therapy (excl. chemotherapy and radiation therapy)Powder and particle technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 08, 2026
mRNA lipid nanoparticle cancer vaccine platform delivering multiple STING activators for enhanced antitumor activity.

|Apr 10, 2026
Resolving heterogeneity of targeted lipid nanoparticles through solution-based biophysical analyses.

Hannah C Geisler, Hannah C Safford, Ajay S Thatte

|Mar 24, 2026
Liver-Detargeted Aromatic Bioreducible mRNA Lipid Nanoparticles Confer Lymph Node Tropism and Robust Antigen-Specific Immunity.

Hannah M Yamagata, Marshall S Padilla, Alex G Hamilton

|Mar 19, 2026
Prodrug-tethered lipid nanoparticles for synergistic messenger RNA cancer immunotherapy.

Qiangqiang Shi, Ningqiang Gong, Jinjin Wang

Pageof 2